MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.43% | 22.26% | 73.31% | -140.17% | -639.30% |
| Total Depreciation and Amortization | -4.88% | 1.80% | 0.85% | -12.15% | -21.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 242.56% | -173.56% | 59.97% | 92.05% | 92.17% |
| Change in Net Operating Assets | -2,135.27% | -786.72% | -547.72% | -128.93% | -97.39% |
| Cash from Operations | -18.53% | -180.10% | 52.99% | 37.29% | 12.57% |
| Capital Expenditure | 48.35% | 38.21% | 32.02% | 3.07% | -110.09% |
| Sale of Property, Plant, and Equipment | -93.13% | -100.00% | -11.11% | 150.00% | 150.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -173.40% | -102.90% | -36.21% | 270.03% | 294.99% |
| Cash from Investing | -176.42% | -104.53% | -36.37% | 261.19% | 286.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.24% | -93.66% | -93.58% | -75.02% | 193.84% |
| Repurchase of Common Stock | 88.36% | 88.43% | 85.82% | 85.58% | -708.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 6,967,400.00% | 39.35% | -- | -- |
| Cash from Financing | 7,141.04% | 6,357.51% | 36.21% | -99.15% | -99.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -253.42% | -210.89% | 288.33% | 145.32% | 1,132.85% |